While in crescentic glomerulonephritis, MDM2 exerts pathogenic effects through p53‐independent NF‐kappa B activation induced intraglomerular inflammation and p53‐dependent parietal epithelial cell hyperplasia and crescent formation 40. Here, MDM2 is linked to crescentic glomerulonephritis.